Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors. (Record no. 27365138)

MARC details
000 -LEADER
fixed length control field 01441 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517163436.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201711s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1744-7674
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1080/13543776.2017.1355908
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Musumeci, Francesca
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20171117
245 00 - TITLE STATEMENT
Title Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Expert opinion on therapeutic patents
Date of publication, distribution, etc. Dec 2017
300 ## - PHYSICAL DESCRIPTION
Extent 1305-1318 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Agammaglobulinaemia Tyrosine Kinase
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Autoimmune Diseases
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Design
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, B-Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, B-Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Patents as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision chemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein-Tyrosine Kinases
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision chemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrroles
General subdivision chemistry
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sanna, Monica
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Greco, Chiara
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Giacchello, Ilaria
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fallacara, Anna Lucia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Amato, Rosario
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schenone, Silvia
773 0# - HOST ITEM ENTRY
Title Expert opinion on therapeutic patents
Related parts vol. 27
-- no. 12
-- p. 1305-1318
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1080/13543776.2017.1355908">https://doi.org/10.1080/13543776.2017.1355908</a>
Public note Available from publisher's website

No items available.